On the fly News and insights, exclusive to thefly.com

MGPI

MGP

$66.10 /

-0.13 (-0.20%)

, BBY

Best Buy

$101.65 /

-1.31 (-1.27%)

09:54
02/26/21
02/26
09:54
02/26/21
09:54

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. MGP (MGPI) downgraded to Hold from Buy at Truist with analyst Bill Chappell stating that his prior thesis of the pandemic driving premium spirit growth and industrial alcohol profitability has been "fully lapped" and now reflected in the price. 2. Best Buy (BBY) downgraded to Outperform from Strong Buy at Raymond James with analyst Bobby Griffin saying he still believes that Best Buy's best-in-class fulfillment capabilities, high mix of essential items, and well positioned peer services/GreatCall initiatives should propel it to gain further market share over both the near-term and long-term, but tells investors in a research note that the downgrade reflects current valuation that does not offer sizable multiple re-rating potential in the coming months and challenging comp sales comparisons. 3. Fate Therapeutics (FATE) downgraded to Neutral from Outperform at Wedbush with analyst David Nierengarten saying while he appreciates the breadth of Fate's technology, from current share price levels, and now that several proofs of concept have been made, de-risking its novel approaches, going forward, he sees higher downside risk and less reward as clinical programs advance and begin to be compared to standards of care. 4. LendingTree (TREE) downgraded to Underperform from Market Perform at Northland with analyst Mike Grondahl saying the company's Q4 report and Q1 guidance was "not exciting, especially on the bottom line." 5. TPI Composites (TPIC) downgraded to Hold from Buy at Craig-Hallum with analyst Eric Stine citing what he views as "soft" 2021 EBITDA guidance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MGPI

MGP

$66.10 /

-0.13 (-0.20%)

BBY

Best Buy

$101.65 /

-1.31 (-1.27%)

FATE

Fate Therapeutics

$91.12 /

+5.015 (+5.82%)

TREE

LendingTree

$283.65 /

+4.17 (+1.49%)

TPIC

TPI Composites

$51.56 /

-9.68 (-15.81%)

  • 15

    Mar

  • 24

    Mar

  • 25

    Mar

  • 09

    Jun

  • 17

    Nov

  • 24

    Nov

  • 06

    Jan

MGPI MGP
$66.10 /

-0.13 (-0.20%)

02/26/21 Truist
MGP downgraded to Hold from Buy at Truist
02/26/21 Truist
MGP downgraded to Hold from Buy at Truist
01/26/21 Craig-Hallum
MGP Ingredients price target raised to $55 from $42 at Craig-Hallum
07/16/20 Berenberg
Berenberg starts 'category leader' MGP Ingredients at Buy
BBY Best Buy
$101.65 /

-1.31 (-1.27%)

02/26/21 DA Davidson
Best Buy price target lowered to $122 from $137 at DA Davidson
02/26/21 Raymond James
Best Buy downgraded to Outperform from Strong Buy at Raymond James
02/26/21 RBC Capital
Best Buy price target lowered to $114 from $130 at RBC Capital
02/26/21 Raymond James
Best Buy downgraded to Outperform from Strong Buy at Raymond James
FATE Fate Therapeutics
$91.12 /

+5.015 (+5.82%)

02/26/21 Truist
Fate Therapeutics price target raised to $135 from $85 at Truist
02/26/21 Wedbush
Fate Therapeutics downgraded to Neutral from Outperform at Wedbush
02/26/21 BofA
BofA starts Fate Therapeutics at Buy with $115 price target
02/26/21 Wedbush
Fate Therapeutics downgraded to Neutral from Outperform at Wedbush
TREE LendingTree
$283.65 /

+4.17 (+1.49%)

02/26/21 Northland
LendingTree downgraded to Underperform from Market Perform at Northland
02/25/21 Truist
LendingTree price target lowered to $335 from $350 at Truist
02/23/21 JPMorgan
LendingTree price target raised to $350 from $330 at JPMorgan
01/13/21 Northland
LendingTree downgraded to Market Perform from Outperform at Northland
TPIC TPI Composites
$51.56 /

-9.68 (-15.81%)

02/26/21 Morgan Stanley
TPI Composites guidance 'confusing at first glance,' says Morgan Stanley
02/26/21 Craig-Hallum
TPI Composites downgraded to Hold from Buy at Craig-Hallum on valuation
02/26/21 Craig-Hallum
TPI Composites downgraded to Hold from Buy at Craig-Hallum
02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.